Story perspectives

Trump to Announce Drug Price Agreements with Major Firms

12/19/2025

Summary

Trump Lowers Drug Prices

U.S. President Donald Trump will announce new agreements on December 19 to lower prescription drug prices.
Major drugmakers, including AbbVie Inc., Merck & Co., Inc., and Gilead Sciences, Inc., are expected to participate.
This follows agreements with five companies, including Pfizer Inc. and Eli Lilly and Co., to provide most-favored-nation prices for Medicaid.
The move aims to narrow the U.S. price gap with other wealthy nations.

Summary

Ellison Completes Merger

David Ellison, CEO of Paramount Skydance Corp., announced the completion of the merger with Paramount after FCC approval.
The deal followed a $16 million settlement with U.S. President Donald Trump over a CBS interview.
Paramount is pursuing a merger with Warner Bros. Discovery, citing better chances of regulatory approval under the Trump administration.
Dealmaking faced challenges from tariffs and macroeconomic uncertainty, contributing to a 17% drop in consumer deal value.

1 of 2

Trump Lowers Drug Prices

U.S. President Donald Trump will announce new agreements on December 19 to lower prescription drug prices.
Major drugmakers, including AbbVie Inc., Merck & Co., Inc., and Gilead Sciences, Inc., are expected to participate.
This follows agreements with five companies, including Pfizer Inc. and Eli Lilly and Co., to provide most-favored-nation prices for Medicaid.
The move aims to narrow the U.S. price gap with other wealthy nations.

1 / 2